Table III.
Open in new tab

Baseline characteristics among GM 17/17 carriers and noncarriers

GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
a

Tested among anti-HSV1 IgG carriers, of which some may also be anti-HSV2 IgG carriers.

b

APOE ε3/ε4 or APOE ε4/ε4.

Table III.
Open in new tab

Baseline characteristics among GM 17/17 carriers and noncarriers

GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
a

Tested among anti-HSV1 IgG carriers, of which some may also be anti-HSV2 IgG carriers.

b

APOE ε3/ε4 or APOE ε4/ε4.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close